Abrogation of B16 melanoma metastases by long-term low-dose interleukin-6 therapy. [electronic resource]
Producer: 19930803Description: 98-109 p. digitalISSN:- 1067-5582
- Animals
- Histocompatibility Antigens Class I -- analysis
- Immunotherapy
- Interleukin-6 -- administration & dosage
- Lung Neoplasms -- secondary
- Melanoma, Experimental -- immunology
- Mice
- Mice, Inbred C57BL
- Receptors, Immunologic -- analysis
- Receptors, Interleukin-6
- Recombinant Proteins -- administration & dosage
- Tumor Cells, Cultured
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.